Pharvaris Total Current Liabilities vs Other Stockholder Equity Analysis
PHVS Stock | USD 23.69 1.40 6.28% |
Pharvaris financial indicator trend analysis is much more than just breaking down Pharvaris BV prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharvaris BV is a good investment. Please check the relationship between Pharvaris Total Current Liabilities and its Other Stockholder Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Total Current Liabilities vs Other Stockholder Equity
Total Current Liabilities vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharvaris BV Total Current Liabilities account and Other Stockholder Equity. At this time, the significance of the direction appears to have strong relationship.
The correlation between Pharvaris' Total Current Liabilities and Other Stockholder Equity is 0.78. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Pharvaris BV, assuming nothing else is changed. The correlation between historical values of Pharvaris' Total Current Liabilities and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Pharvaris BV are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Total Current Liabilities i.e., Pharvaris' Total Current Liabilities and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.78 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Current Liabilities
Total Current Liabilities is an item on Pharvaris balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Pharvaris BV are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Other Stockholder Equity
Most indicators from Pharvaris' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharvaris BV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, Pharvaris' Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 66 M in 2024, whereas Selling General Administrative is likely to drop slightly above 16 M in 2024.
Pharvaris fundamental ratios Correlations
Click cells to compare fundamentals
Pharvaris Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pharvaris fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.6M | 101.1M | 212.1M | 167.7M | 398.7M | 418.6M | |
Other Current Liab | 1.4M | 4.5M | (2.5M) | 10.9M | 11.1M | 11.6M | |
Total Current Liabilities | 1.9M | 5.3M | 7.0M | 18.2M | 14.6M | 7.5M | |
Total Stockholder Equity | 18.7M | 95.8M | 205.0M | 149.3M | 384.0M | 403.3M | |
Net Debt | (20.3M) | (98.6M) | (209.1M) | (161.4M) | (391.0M) | (371.4M) | |
Retained Earnings | (18.5M) | (44.5M) | (87.6M) | (164.2M) | (265.9M) | (252.6M) | |
Accounts Payable | 509.9K | 656.4K | 2.1M | 6.0M | 2.9M | 2.0M | |
Cash | 20.3M | 98.6M | 209.4M | 161.8M | 391.2M | 410.8M | |
Non Current Assets Total | 12.9K | 147.8K | 523.4K | 886.2K | 843.1K | 885.3K | |
Cash And Short Term Investments | 20.3M | 98.6M | 209.4M | 161.8M | 391.6M | 411.1M | |
Net Receivables | 210.8K | 569.6K | 700.1K | 382.5K | 1.0M | 1.1M | |
Liabilities And Stockholders Equity | 20.6M | 101.1M | 212.1M | 167.7M | 398.7M | 418.6M | |
Non Current Liabilities Total | 509.9K | 847.0K | 150.8K | 249.4K | 43.6K | 41.4K | |
Other Stockholder Equity | 36.5M | 138.0M | 278.7M | 289.2M | 615.8M | 646.6M | |
Total Liab | 1.9M | 5.3M | 7.1M | 18.5M | 14.6M | 7.6M | |
Net Invested Capital | 18.7M | 95.8M | 205.0M | 149.3M | 384.0M | 403.3M | |
Total Current Assets | 20.6M | 101.0M | 211.6M | 166.8M | 397.9M | 417.7M | |
Accumulated Other Comprehensive Income | 392.1K | 2.0M | 9.8M | 20.2M | 27.9M | 29.3M | |
Net Working Capital | 18.7M | 95.6M | 204.6M | 148.6M | 383.2M | 402.4M | |
Common Stock | 131.0K | 235.7K | 4.0M | 4.1M | 6.3M | 6.6M | |
Net Tangible Assets | 18.6M | 95.6M | 205.0M | 149.3M | 171.6M | 104.1M | |
Other Current Assets | 47.5K | 1.8M | 1.5M | 4.6M | 5.6M | 5.9M | |
Capital Stock | 131.0K | 235.7K | 4.0M | 4.1M | 6.3M | 6.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.